Although VR approaches have been studied as a tool for therapy for PD patients, this proposal is, to our knowledge, the first systematic attempt to develop a VR methodology as a tool for quantifying motor dysfunction in patients undergoing dopamine transporter imaging with [123I]FP-CIT SPECT/CT. The gene discussed is SLC6A3; the disease is Parkinson disease.